Skip to content

Drug interactions

Dabigatran + Dipyridamole

Severity: Major

Dabigatran and Dipyridamole: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dipyridamole adds antiplatelet activity to dabigatran's anticoagulation and, as a P-glycoprotein inhibitor, may increase dabigatran exposure. Both effects raise bleeding risk, especially in renal impairment.

What this interaction means in plain words

Dabigatran and Dipyridamole can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Additive effects on hemostasis plus P-glycoprotein inhibition by dipyridamole that raises dabigatran levels.

What to do

Monitor for bleeding and renal function. Avoid the combination in patients with reduced creatinine clearance, following dabigatran labeling for P-gp inhibitors.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dabigatran and Dipyridamole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dabigatran with Dipyridamole?

MediHelp rates the interaction as major. Dabigatran and Dipyridamole can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Dipyridamole adds antiplatelet activity to dabigatran's anticoagulation and, as a P-glycoprotein inhibitor, may increase dabigatran exposure. Both effects raise bleeding risk, especially in renal impairment.

How serious is the interaction between Dabigatran and Dipyridamole?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for bleeding and renal function. Avoid the combination in patients with reduced creatinine clearance, following dabigatran labeling for P-gp inhibitors.

What other medicines interact with Dipyridamole?

MediHelp also lists interactions of Dipyridamole with, for example, Riociguat, Adenosine, Betrixaban. The full list is on the Dipyridamole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in